Verona Pharma plc (I9SA) — Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Verona Pharma plc (I9SA) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow (€22.82 Million) in capital expenditures (€11.00K). Check Verona Pharma plc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

€22.82 Million

EUR

Capital Expenditures

€11.00K

EUR

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Verona Pharma plc (None–None)

Year-by-year Capital Reinvestment Ratio for Verona Pharma plc from None to None. See Verona Pharma plc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow